Dr. Martens plc DOCMF
Set alert
0.85 USD 0.00 0.00%
At close · Nov 2
0.9266 Day range 0.9266
0.8143 52-week range 1.21
- YTD
- -17.48%
- 1 year
- -29.75%
- Open
- 0.9266
- Prev close
- 0.85
- Mkt cap
- 813.67M
- Vol
- 100
- Avg vol
- 5.44K
- EPS
- 0.03
- P/E
- 28.33
More statistics
- Low
- 0.9266
- High
- 0.9266
6M chart
Events in this range
- May 19, 2026Earnings: 0.04668; estimate —; surprise —%
- Aug 27, 2026Dividend: 0.0231019
- Aug 28, 2026Dividend: 0.017
Signals (18)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 31, 2026 | 3 months ago |
| RSI: Overbought | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 16, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 4 months ago |
| RSI: Overbought | Jun 16, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| RSI: Overbought | May 29, 2026 | 5 months ago |
| SMA: Bearish | May 20, 2026 | 5 months ago |
| SMA: Bullish | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | May 19, 2026 | 5 months ago |
| RSI: Overbought | May 19, 2026 | 5 months ago |
| SMA: Bullish | May 6, 2026 | 6 months ago |
Financial health
Altman Z-Score
5.01 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 25.8×
FY 2017 5y median 13.7× FY 2026
P/S 0.8×
FY 2017 5y median 1.0× FY 2026
P/B 1.7×
FY 2017 5y median 2.3× FY 2026
P/FCF 5.3×
FY 2017 5y median 6.2× FY 2026
EV/EBITDA 5.9×
FY 2017 5y median 6.8× FY 2026
EV/Sales 1.1×
FY 2017 5y median 1.4× FY 2026
FCF Yield 18.9%
FY 2017 5y median 16.2% FY 2026
Profitability
Gross Margin 66.0%
FY 2017 5y median 59.7% FY 2026
Operating Margin 7.9%
FY 2017 5y median 14.4% FY 2026
Net Margin 3.1%
FY 2017 5y median 7.9% FY 2026
ROE 6.6%
FY 2017 5y median 18.8% FY 2026
ROIC 5.7%
FY 2017 5y median 11.0% FY 2026
ROA 2.7%
FY 2017 5y median 7.3% FY 2026
Growth (YoY)
Revenue -2.6%
FY 2017 FY 2026
Operating Income 7.5%
FY 2017 FY 2026
EPS (diluted) 386.0%
FY 2017 FY 2026
Free Cash Flow -34.3%
FY 2017 FY 2026
Financial Health
Current Ratio 2.6×
FY 2017 5y median 2.8× FY 2026
Quick Ratio 1.6×
FY 2017 5y median 1.5× FY 2026
Debt / Equity 1.1×
FY 2017 5y median 1.1× FY 2026
Net Debt / EBITDA 1.5×
FY 2017 5y median 1.5× FY 2026
Interest Coverage 2.2×
FY 2017 5y median 3.9× FY 2026
Dividends
Dividend Yield 4.0%
FY 2017 5y median 4.0% FY 2026
Payout Ratio 103.4%
FY 2017 5y median 83.5% FY 2026
Annual · latest fiscal year ends 2026-03-31
